Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Bone Neoplasms × spartalizumab × Clear all

Sponsor

Conditions

Melanoma 7 Pancreatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Triple Negative Breast Neoplasms 4 Head and Neck Neoplasms 3 Sarcoma 2 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Liver Neoplasms 2 Carcinoma, Renal Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Metastatic Pancreatic Ductal Adenocarcinoma 1 Lymphoma, Large B-Cell, Diffuse 1 Lung Neoplasms 1 Kidney Neoplasms 1 Kidney Diseases 1

Interventions

Vincristine 2 Temozolomide 2 Magnetic Resonance Spectroscopy 2 Irinotecan 2 Doxorubicin 2 Cyclophosphamide 2 selinexor 1 samarium Sm-153 lexidronam 1 robatumumab 1 pembrolizumab 1 pegfilgrastim 1 angiotensin I (1-7) 1 Zoledronic Acid 1 Transcranial Direct Current Stimulation 1 Tranexamic Acid 1 Sunitinib 1 Standard of Care 1 Sodium Pertechnetate Tc 99m 1 Sodium Chloride 1 Samarium 1 Radiosurgery 1 Radiation 1 Proton Therapy 1 Pregabalin 1 Practice Guidelines as Topic 1 Plicamycin 1 Palliative Care 1 Nivolumab 1 Neutrons 1 Methods 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡